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Summary
Athymic nude mice recover from an infection with recombinant vaccinia virus (VV) encoding
murine interleukin 2 (IL2), but treatment with a mAb to 1172 accentuated infection. Administration
ofamAb against interferon y (IFN-y) to mice infected with the ID2-encoding virus completely
prevented the IIr2-induced mechanisms of recovery. Both asialo-GMi+ (NK) and asialo-GM, _
(non-NK) cells were participants in the IFN-y-mediated recovery of nude mice from infection
with the IIr2-encoding VV recombinant . Depletion of asialo-GMI+ cells exacerbated infection,
though not as much as anti-IFN-y mAb. In vitro, both asialo-GMI+ and asialo-GM, - nude
mouse splenocytes produced IFN-y in response to IL2 .
A
ntiviral cytotoxic T (Tc)' cells play a crucial role in
recovery from primary virus infections (1-5), including
vaccinia virus (VV) (6) . T cell-deficient nude mice are there-
fore unable to resolve a VV infection and usually die of a
disseminated vaccinial disease. However, nude mice can suc-
cessfully overcome infection with recombinant VV that en-
code murine or human IL2 (7, 8) . Both nude and normal
mice infected with the recombinantVVencoding murine IL2,
VVHAIL2, have elevatedNK cell responses coinciding with
the rapid clearance of this virus (9) . In addition, our studies
(9) using beige mice also suggested that both NK cell-
dependent and -independent mechanisms may be involved
in the rapid clearance ofVVHA-IL2 compared with a con-
trol virus,VVHATK. Virus-encoded IL2 could have induced
a cascade of immunological events, includingNK cell activa-
tion, which contributed to rapid clearance of VVHA-IL2
and recovery of nude mice. In this report, we present evi-
dence that the recovery of nude mice from infection with
VVHA-IL2 is mediated through the release ofIFN-y by both
asialo-GMI+ (asGMI+) (NK) and as-GMi - (non-NK) cells.
The antiviral activity of the 11,2-triggered IFN-y was abol-
ished by treatment with a mAb to IFN-y, which prevented
clearance of VV-HA-IL-2 and resulted in 100% mortality in
an otherwise sublethal infection .
Mice.
￿
6-9-wk-old female athymic Swiss outbred nude mice,
raised under specific pathogen-free conditions, were obtained from
' Abbreviations used in this paper.MTD, mean time to death ; Tc, cytotoxic
T cells; TK, thymidine kinase; VV, vaccinia virus.
the Animal Breeding Establishment of The John Curtin School
of Medical Research (JCSMR) .
Viruses.
￿
Construction ofVV recombinants from the wild-type
virus, VVWR, has been described in detail elsewhere (7). Briefly,
the 11,2-encoding recombinantWHA-11,2 was constructed by
the insertion ofHSV thymidine kinase (TK) gene and a chimeric
promoter-11,2 fragment into the HindIII F region ofaVV recom-
binant, VVHA-PR8 (10), which had been engineered to express
the influenza A/PR/8/34 hemagglutinin (HA) . The control virus
VVHATK encoding HSVTK and A/PR/8/34HA but not 11,2
was similarly constructed . Murine 11,2 was detectable in culture
supernatants of murine L929 or human 143B cells within 4-6 h
ofinfection withWHA-11,2 . Virus stocks, prepared from infected
CV-1 cells, were diluted in 2 ml of gelatin saline to contain the
desired PFU/ml and dispersed by sonication twice for 5 s at 50W
before use.
Cell Lines.
￿
YAC-1 (H-2'), a line derived from Moloney leu-
kemia virus-induced lymphoma in A/Sn mouse (11), CV 1, a cell
line derived from African green monkey kidney (12) and 143A a
human osteosarcoma cell line (13) were maintained in DMEM
(Gibco Laboratories, Grand Island, NY) supplemented with anti-
biotics and 5% heat-inactivated FCS (Flow Laboratories, North
Ryde, Australia) . YAC-1 cells were used as targets in NK cytotox-
icity assays,CV-1 cells were used for the preparation ofvirus stocks,
and 143B cells were used for virus titrations as described else-
where (9) .
Cytotoxicity Assays.
￿
The standard "Cr-release assays were car-
ried out in triplicate for each E/T ratio as described in detail else-
where (9) .
Antisera/Monoclonal Antibody . Rabbit anti-asGM,, a poly-
clonal antibody (Wako Pure Chemicals Industries, Osaka, Japan)
was used to deplete as-GM,' (NK) cells in vivo. Anti-as-GM, was
administered intravenously, followed by the intranasal route after
light anesthesia with ether. The procedure involving antibody ad-
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and Guffee (14), where treatment with anti-as-GM, by the two
routes was superior to theintravenous route alone andwaspartic-
ularly essential for the depletion of NK cells in the lung. Treat-
ment was continued every day after the day of infection, since
preliminary depletion experiments showed there-emergence ofas-
GM,' cells (assessed by flow cytometry and lysis ofYAC-1 targets)
in spleens of mice infected with VV-HAIL2. Anti-as-GM, an-
tiserum treatment does not deplete as-GM,- NK cell precursors
and 11,2 is known to give rise to as-GM,' cells from precursors
that lack the marker (15).
Purified ratanti-mouse IFN-y, aneutralizing mAbwith specific
activity of 13,000 U/ml (5,700 U/mg)wasobtained from LeeBio-
molecular Research Inc., San Diego, CA. A rat anti-mouse hy-
bridoma line, S4B6.31, which is a subclone of the originally de-
scribed clone, S4B6 (16), was obtained from DNAX Research
Institute of Molecular and Cellular Biology (Palo Alto, CA). The
clone secretes mAb (IgGu subclass) to murine 11,2. The mAb was
obtained as ascites, grown in pristane-primed outbred nude mice,
andused after partialpurification by ammonium sulphate precipi-
tation.Theprecipitate wasdissolved in PBS anddialyzed threetimes
against PBS at 4°C, filter sterilized, and stored at -20°C.
The following mAbs and antiserum were used at the dilutions
indicated forin vitrocell depletionwith C: antiThy-1.2, cloneF7D5
(Serotec Ltd., Blackthorn Bicester, England) at adilution of 1/1,000;
anti-CD4, cloneRL174 (17), andanti-CD8, clone 31M (18), kindly
provided by Dr. R. Ceredig (John Curtin School of Medical Re-
search) at dilutions of 1/5; and anti-as-GM, at a dilution of 1:50
(1:5 for some experiments). Low toxicity rabbit C (Cedarlane
Laboratories, Ltd., Canada) was used at a final dilution of 1:10.
Assay for 11,2.
￿
The presence of 11,2 in supernatants of VV
HAIL2-infected cells, sera, or peritoneal fluidofmice wasassessed
by CTLI,2 cell proliferation and uptake of ['H]TdR as described
elsewhere (19).
Administration ofMurine rIL2 and rIFN-y to Nude Mice infected
with VV-HATK. Affinity column purified murine rIL2, with a
specific activity of 64,000 U/ml, was kindly provided by Dr. P.
Hodgkin, DNAX Research Institute of Molecular and Cellular
Biology. Murine IFN-y (300,000 IU/ml) was a kind gift of
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Boehringer Ingelheim, Vienna, Austria. Nude mice that hadbeen
infected 1 hearlier with VVHATK were given600 Ui.p. of mu-
Tine rIL2 or rIFN-y and dosed thereafter every 8 h for a period
of5d. Uninfected controls were treated similarly to assess the tox-
icity of the cytokines.
Assay IFN-y in Supernatants ofNude Mouse Splenocyte Cultures
Stimulated with 11,2. Splenocytes from outbred nude mice were
cultured in the presence of rII1,2 to determine whether as-GM,+
andas-GM, - cellsproduced IFN-y. Whole Splenocytes (5 x 106
cells treatedwith Conly)were cultured in 1 ml ofcomplete DMEM
containing 5 x 10-4 1VI 2-ME and 100 U rIL2 for 3d at 37°C
in a humidified atmosphere containing 5% C02 in air. Similarly,
Splenocytes depleted of as-GM,' cells (5 x 106 cells treated with
anti-as-GM, + C) were cultured under the same conditions. Con-
trols were not exposed to IL2. Presence of IFN-y in the culture
supernatants wasdetermined using acommercial sandwich ELISA
(Holland Biotechnology bv, Leiden, Netherlands). The ELISAwas
performedaccording to themanufacturers' instructions. IFN-y ac-
tivity (IU/ml) was calculated from optical density values using a
standard curve.
Results
VVHA-IL2 Is Cleared Rapidly from Organs of Nude
Mice. The kinetics ofvirusreplication in organs of VV-HA
TK- or VVHA-IL2-infected mice is shown in Fig. 1. Both
the viruses successfully seeded theovaryandlung, butwhereas
VVHATK titers rose sharply 3 d after infection, VVHA-
IL2 was rapidly cleared and virus could no longer be recov-
ered beyond 6 d after infection. VVHATK persisted for at
least 13 d after infectionin these organs, by whichtime mice
were beginningto die. Thereplication ofthese recombinant
viruses in spleens and brains of nude mice showed a some-
what different pattern. VVHAIL2 was detected in spleens
12 h afterinfectionbut could nototherwise be recoveredfrom
spleens or brains. VVHATK persisted in spleens over the
entire course of infection andwasrecoveredfrom brains after
LUNGS
Figure 1.
￿
Kinetics of recombinant
vaccinia virus replication in organs of
BRAIN
￿
outbred nude mice. Female nude mice
between theages of 6 and 9 wk were
infected intravenously with 107PFU of
VVHA-IL2 ((]) or VVHATK (N)
and on thedays indicatedorgans were
removedto determinevirustiters. Data
shownarethegeometricmeansofthree
individual organs perdayforeach group ..........................................................._.............................
￿
± SEM. The sensitivity of virus de-
tection in the assay system used is
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dotted line.4-5-wk-old outbred nude mice were injected i.v . with 107 PFU VV-HA-IL2 or VV-HA-TK. On days 0 (day of infection), 1, 2, 3, and 4, mice
were given -500 Kg i.p . of anti-IL-2 mAb (+) and controls were left untreated (- ) . Mortality was monitored in all groups . Nude mice treated
with anti-IL-2 mAb only all survived (data not shown) .
' Mean time to death .
t Numbers in parentheses indicate the days on which individual mice died .
the 4th day of infection and persisted at close to the peak
level attained after the 10th day of infection .
The kinetics ofVV-HA-IL2 clearance suggested that the
mechanisms induced by virus-encoded IL2 operated as early
as the 3rd day of infection, and as reported before (9), coin-
cided with an elevated splenic NK cell response (data not
shown) .
The Effect ofAnti-IL2 mAb Treatment on Viral Titers and
Survival ofNude Mice . In order to establish that IL2 was
indeed produced in vivo during an infection with VV-HA-
IL2 and that the highly attenuated phenotype of this virus
was due to the antiviral mechanism(s) induced by virus-
encoded 11,2, groups of outbred nude mice infected intrave-
nously with 107 PFU of VV-HA-IL2 or VVHATK were
simultaneously treated with a mAb to murine 11,2 . Treat-
ment with the mAb to 11,2 should reduce the activity of
IL2 produced in vivo during infection with VVHA-IL2 and
increase the severity of infection . As expected, all seven mice
infected with VV-HA-IL2 and treated with themAb to IL2
died, whereas mice given virus alone survived (Table 1) .
Antibody-treated nude mice infected withVVHATK all died
with a mean time to death (MTD) of 7.3 d, which was not
significantly different (p > 0.05) from those given VV-HA
TK only.
5 d after infection, mean titers of VVHA-IL2 in ovaries
and lungs of mice treated with the mAb were significantly
higher (p < 0.001) than untreated controls (Table 2) . Only
marginal increases were apparent inVVHATK titers in ova-
ries and lungs of mice treated with the antibody compared
with untreated controls .
NK Cell Depletion In Vivo Results in Enhanced VVHA-IL2
Titers. We investigated the possible causal relationship be-
tween 11,2-activated NK cells and their antiviral effects in
vivo. Outbred nude mice were depleted of as-GM, + cells by
repeated junctions with a polyclonal antibody to as-GM I .
The antibody treatment resulted in the elimination of>98%
of splenic as-GM, + cells, as assessed by flow cytometry, and
completely abolished the cytolytic activity on YAC-1 targets
(data not shown) .
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Virtually no cytolytic activity on YAC-1 or L939 targets
could be demonstrated in spleens of recombinant virus-infected
mice that had been treated with anti-as-GMt (data not
shown) .
Significant increases in the mean VV-HA-IL2 titers in lungs
and ovaries ofNK cell-depleted nude mice were demonstrable
3 and 5 d after infection (Table 3) . NK cell depletion in nude
mice infected withVVHATK resulted only in marginal and
insignificant increases in the mean viral titers in these organs
compared with control, untreated nude mice. Despite a satis-
factory depletion ofNK cells, ovarian VV-HA-IL2 titers were
never as high as levels ofVVHATK . This may have been
a reflection of our earlier finding (Karupiah, G., andR . V
Blanden, manuscript submitted for publication) that anti-as-
GM, partially inhibited VV infection of murine ovaries .
Separate groups of nude mice that were treated with anti-
as-GMt and infected with either recombinant virus, were
Table 2 .
￿
The Effect of Anti-IL-2 mAb Treatment on
VV-HA-IL2 and VV-HA-TK Titers in Nude Mice
" 4-5-wk-old mice were infected with virus and treated with anti-IL-2
mAb as described for Table 1 . On day5 after infection, mice were killed
and virus titers in lungs and ovaries were determined.
t Data shown are the geometric means of four individual organs per
group ± SEM.
S Increase in titer highly significant (p < 0.001 ; Student's t-test) com-
pared with untreated group infected with VV-HA-IL2 only.
Table 1 .
No . of
mice
The Effect of Anti-IL-2 mAb
Virus
Treatment on the Survival of
Anti-IL-2
mAb treatment
Nude Mice Infected with
Percent
survival
VV-HA-IL2 or VV-HA-TK
MTD"
(death on days p.i.)t
7 VV-HA-IL2 - 100 -
7 VV-HA-IL2 + 0 6.9 (5, 5, 6, 7, 8, 8, 9)
7 VV-HA-TK - 0 7.6 (6, 7, 7, 7, 8, 8, 10)
7 VV-HA-TK + 0 7.3 (6, 6, 7, 7, 7, 9, 9)
Virus infection
and treatment*
Logio virus titers
Ovaries
± SEMI
Lungs
VV-HA-TK 8 .3 ± 0.1 6 .3 ± 0.1
VV-HA-TK +
anti-IL-2 mAb 8 .8 ± 0.2 6 .7 ± 0.3
VV-HA-IL2 3 .0 ± 0.1 3 .3 ± 0.1
VV-HA-IL2 +
anti-IL-2 mAb 7.8 ± 0.45 5.6 ± 0.2STable 3 .
￿
The Effect of as-GM Antiserum Treatment in
Nude Mice on Recombinant VV Replication
anti-as-GM,
￿
8.6 ± 0.1 6.5 ± 0.1
VV-HA-IL2 +
NRS
￿
4.3 ± 0.1 4.2 ± 0.1
VV-HA-IL2 +
anti-as-GM,
￿
5.3 ± 0.2 5.8 ± 0.1
6-9-wk-old female outbred nude mice were given antiserum to as-GM1
(stock diluted to 1/5 in PBS) in a 150 P,1 volume i.v . and 50 E,.l i.n . on
days - 5, - 3, -1, 0, 1, and 2 for Exp . 1 and similarly for Exp . 2 with
additional treatments on days 3 and 4 . Control mice were given only
PBS (Exp. 1) or normal rabbit serum (NRS) (Exp . 2) . On day 0, mice
were injected i.v. with 107 PFU virus, and on the days indicated for each
experiment, organs were removed for determination of viral titers .
t Data shown are the geometric means of titers of organs from four in-
dividual mice ± the SEM .
monitored for signs of morbidity and mortality . All mice
that were infected withVVHATK died within 14 d after
infection, andNK cell depletion did not accelerate theMTD
(data not shown) . Despite the enhanced virus titers (Table
3), no mortality was recorded inNK cell-depleted nude mice
that had been infected with VV-HA-11,2 . These results indi-
cate that as-GMi+ NK cells contribute to control of VV
HAIL2 infection in nude mice, but that other mechanisms
may be involved .
EnhancedVVHA-IL2 Replication In Vivo after Treatment with
IFN-y Antibody. The 11,2-induced antiviral mechanism(s)
could have been mediated in vivo either through direct cyto-
lysis of virus-infected cells and/or through secretion of anti-
viral factors. There was a possibility that virus-encoded IL2,
apart from augmentingNK cytolytic activity, also triggered
the secretion of antiviral factors such as IFN-y and TNF-ci
by as-GMt+ (NK) and as-GMt- (non-NK) cells. To deter-
mine the role of host-derived IFN-y in recovery fromVV
HAIL2 infection, nude mice were treated with a neutralizing
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Table 4 .
￿
The Effect of Treatment with mAb to IFN-y in
Nude Mice on the Replication ofVV-HA-TK or VV-HA-IL2
6-wk-old female nude mice were given 500 tul of mAb to IFN-y i .p .
on days -1, 0, 1, and 2 for Exp . 1 and an additional day (day 3) for
Exp . 2 . Mice were infected i.v . with 107 PFU virus on day 0, and 3
(Exp . 1) or 5 (Exp . 2) d later, mice were killed and virus titers in organs
were determined . 1 U ofmAb neutralizes 10 U of murine IFN-y in vitro .
Data shown are the geometric means of logo virus titers ± SEM of
four individual lungs or pairs of ovaries .
mAb to IFN-y and virus titers were determined in organs,
3 and 5 d after infection .
Titers ofVVHATK in ovaries and lungs of mice treated
with mAb to IFN-y increased by 0.8-0.9 loglo PFU over
untreated controls 3 d after infection (Table 4) . In marked
contrast, mAb treatment in VVHAIL2-infected mice resulted
in increases of 2.5 loglo PFU in ovaries and 1.8 loglo PFU
in lungs . By day 5 after infection,VVHATK titers inmAb-
treated mice were only 0.4 loglo PFU above control levels
in these organs, but VVHAIL2 titers in ovaries and lungs
of mAb-treated mice increased by 4.8 and 2.3 loglo PFU,
respectively, above untreated controls. These results indicate
that IFN-y plays a crucial role in clearance of VVHAIL2
in both ovaries and lungs of nude mice.
mAb to IFN-y Inhibits the Ability of Nude Mice to Survive
Infection with VV-HA-I1,2. The above data suggested that
IFN-y, triggered by virus-encoded 11,2, played an impor-
tant role in virus clearance. The effect of anti-IFN-y mAb
treatment on survival of nude mice infected withVVHA
IL2 was next determined . None of the nude mice given the
mAb against IFN-y survived infection with VVHA-IL2,
which was in sharp contrast to the group of mice givenVV
HAIL2 only in which all the animals survived (Table 5) .
Moreover, the concentration of mAb administered affected
the MTD. For instance, nude mice infected with VV-HA-
Exp .
Days after Virus and
infection treatment"`
Logo virus titers
± SEMI
Ovaries Lungs Exp .
Days after
infection
Virus infection
and treatment
Logo virus titers
± SEW
Ovaries Lungs
1 3 VV-HA-TK + 1 3 VV-HA-TK 7.5 ± 0.2 6.3 ± 0.2
PBS 7.5±0.3 6.3±0.2 VV-HA-TK +
VV-HA-TK + IFN-y mAb 8.3 ± 0.3 7.2 ± 0.2
anti-as-GM, 7.8 ± 0 .1 6.7 ± 0.4 VV-HA-IL2 5.0 ± 0.2 5.1 ± 0.3
VV-HA-IL2 + VV-HA-IL2 +
PBS 5.0±0 .2 5.2±0.1 IFN-y mAb 7.5 ± 0.3 6.9 ± 0.3
VV-HA-IL2 + 2 5 VV-HA-TK 8.6 ± 0.2 6.5 ± 0.2
anti-as-GM, 5.8 ± 0 .1 6.4 ± 0.4 VV-HA-TK +
2 5 VV-HA-TK + IFN-y mAb 9.0 ± 0.1 6.9 ± 0.2
NRS 8.3 ± 0.3 6.2 ± 0.2 VV-HA-IL2 4.0 ± 0.1 4.2 ± 0.1
VV-HA-TK + VV-HA-IL2 +
IFN-y mAb 8.8 ± 0.1 6.5 ± 0.2Table 5 .
￿
Mortality in Nude Mice Treated with Anti-IFN-y
mAb and Infected with VV-HA-TK or VV-HA-IL2
10-wk-old female nude mice were given 500 U i.p. ofmAb to IFN-y
on days -1, 0, 1, 2, and 3 . Mice were infected i.v. with 107 PFU of
virus on day 0 . Control mice were left uninfected .
" Mean time to death .
IL2 and treated with 100U ofmAb for four successive days
had aMTD of 11.0 d whereas a similar treatment protocol
with 500 U of themAb resulted in anMTD of 6.0 d (Table
6) . mAb-treated mice that died between 5 and 8 d after in-
fection withVVHA-IL2 had no obvious signs of a vaccinial
disease but appeared to suffer from the toxic effects of 11,2,
manifested in the form of vascular leak syndrome (eryth-
roderma, ascites, and massive accumulation of mononuclear
cells in the peritoneal cavity) . High levels of 11,2 could be
detected in sera and ascites ofWHA-11,2-infected mAb-
treated mice but not in mice given virus alone (data not
shown) . However, no significant levels of TNF-ot could be
detected in sera and ascites of these mice.
Treatment with Anti-IFN-ymAb in VVHA-IL2-infected Mice
Results in EnhancedNK CellActivity . We investigated whether
treatment with the mAb to IFN-y inVVHA-IL2-infected
mice prevented the enhancedNK cell response previously ob-
served (9) . The splenic NK activity in mice infected with
VVHA-IL2 and treated with the mAb wasmore than three-
fold higher than activity induced by infection withVV-HA
IL2 only (Fig. 2) . Using a panel of antiserum and mAb and
C, the splenocytes fromVVHATK-infected mice mediating
lysis of YAC-1 targets were phenotyped as as-GM, +,
Thy-1.2 :', CD4- , and CD8 - . Similarly, lysis of YAC-1
targets by splenocytes from VVHAIL2-infected mice was
mediated mainly by as-GM, +, Thy-1.2=, CD4 - , and CD8 -
effectors, although some lysis was mediated by effectors that
lacked these markers . On the other hand, there were at least
two distinct populations of splenocyte effectors from VV-
HA-11,2-infected mice that had been treated with the mAb
to IFN-y . One was as-GMI+, Thy-1.21 , CD4 - , andCD8-
and the other was as-GM,-, Thy-1.21 , CD4 - , and CD8- .
The phenotype of peritoneal cells obtained from the mAb-
treated andVVHA-IL2-infected mice and that lysed YAC-1
targets had a similar phenotype to splenocytes . Both spleno-
cyte and peritoneal effectors obtained from these mice were
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Table 6 .
￿
The Effect ofIncreasing IFN-y mAb Concentration
on Mortality of Nude Mice Infected with VV-HA-IL2
4
￿
400 U
￿
VV-HA-IL2
￿
7.8 (6, 7, 8, 10)
2
￿
400 U
￿
-
￿
-
4
￿
500 U
￿
VV-HA-IL2
￿
6.0 (5, 5, 6, 8)
2
￿
500 U
￿
-
￿
-
6-wk-old female nude mice were given i.p . varying concentration ofmAb
to IFN-y on days -1, 0, 1, 2, and3 . Mice were infected i.v . on day
0 with 107 PFU virus and controls were left uninfected .
quite resistant to treatment with anti-as-GM, + C, despite
the use of 10-fold higher concentration of the antiserum .
Effect ofAdministration ofrIL2 or rIFN-,y on Mortality and
Survival Time ofNude Mice Infected with VVHATK. The
above data clearly established that IFN-y is involved in the
rapid clearance of VVHAIL2 and recovery of nude mice.
It was therefore of interest to determine whether the conse-
quences oflocal IIr2 production in foci ofVVHAIL2 infec-
tion and subsequentIFN-y secretion and viral clearance could
be mimicked by the administration of exogenous rID2 or
rIFN-y during infection with VVHATK .
Groups of three to five outbred nude mice infected intra-
venously with 107 PFU VVHATK were given 600 U of
rIIr2 or rIFN-y intraperitoneally every 8 h for a period of
5 d . No morbidity, mortality or signs of toxicity were recorded
in control groups of mice given only rIL2 or rIFN-y (Table
7) . All mice given VVHA-IL2 alone survived with no overt
disease. Nude mice infected withVVHATK alone showed
signs of disease by 6 d after infection and all mice died with
anMTD of 12.2 d (Table 7) . Treatment with exogenous rI1r2
or rIFN-y delayed the onset of disease signs that appeared
between 11-16 d after infection, and significantly (p < 0.001)
prolonged survival of nude mice . Nevertheless, all mice that
had been infected with VVHATK and treated with either
rI1r2 or rIFN-y succumbed to disseminated disease and died
with MTD of 23.4 and 25.8 d, respectively.
These results suggested that systemic IIr2 or IFN-y in-
hibited VVHA-TK replication during the 5-d course of treat-
ment, but that virus persisted and then grew to lethal levels
after treatment was withdrawn.
Both as-GM, + and as-GM, - Nude Mouse Splenocytes Pro-
duce IFN-y in Response to Stimulation with IL2 In Vtra To
determine whether as-GMI+ and especially as-GMI - lym-
Virus and/or
mAb treatment
No . of
mice
Percent
mortality
MTD'
(death on days p .i .)
No . of
mice
mAb
concentration
Infected/
uninfected
MTD
(days p .i . of death)
mAb only 3 nil - 4 100 U VV-HA-IL2 11.0 (9, 11, 11, 13)
VV-HA-TK 5 100 15 .4 (12, 14, 15, 18, 18) 2 100 U - -
VV-HA-TK + 4 200 U VV-HA-IL2 9.8 (7, 9, 10, 13)
mAb 5 100 14.6 (13, 13, 14, 16, 17) 2 200 U - -
VV-HA-IL2 5 nil - 4 300 U VV-HA-IL2 8.5 (7, 8, 9, 10)
VV-HA-IL2 + 2 300 U - -
mAb 5 100 9.6 (5, 6, 7, 13, 17)EFFECTOR : TARGET RATIO
Figure 2 .
￿
The effect of IFN-y mAb treatment on splenic NK cell ac-
tivity. 6-8-wk-old female nude mice were given 500U i.p. of anti-IFN-y
mAbon days -1, 0, 1, 2, and 3 . Mice were infected intraperitoneally with
107 PFU virus on day 0, and 5 d later the splenic cytolytic activity (per-
cent specific lysis) on S1Cr-labeled YAC-1 targets was determined using
pooled splenocytes from VVHATK-infected ("), VVHATK-infected
mAb-treated (O), VVHAIL2-infected ("), or VVHAIL2-infectedmAb-
treated (O) mice. The assay was carried out in triplicate for each E/T
ratio and SEM were <5% .
Discussion
1500
" 8-wk-old male nude mice were given 10 7 PFU virus i.v . 1 h after infection, mice were given 600U i.p . of rIL-2 or rIFN-y and thereafter every
8 h for a period of 5 d . Controls were given PBS only (-) .
t Significant, p < 0.001, Student's t-test, compared with group given VV-HA-TK only .
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phoid cells from nude mice produced IFN-y after stimula-
tion with l1r2, splenocytes, either whole or depleted of as-
GMt+ cells, were cultured in media containing 100 U/ml
of rIIr2 for 3 d, after which the presence of IFN-y in cul-
tures was assayed using an ELISA . More than 40 U/ml of
IFN-y was detected in whole splenocyte culture supernatants,
whereas between 26 and 30 U/ml of the cytokine was de-
tected in supernatants of cultures depleted of as-GMi+ cells.
IFN-y was not detected in supernatants of control cultures
that had been maintained in the absence of 11,2 .
Athymic, nude mice lack mature T cells and are therefore
unable to mountT-dependentimmune responses. They usu-
ally succumb to VV because of a deficiency in functional
CD8+ Tc cells which are essential for recovery from primary
poxvirus infections (1, 2, 7, 8) . T cells are the principal
producers of Il,2, which is pivotal for the generation and
regulation ofanimmune response (20) . Apart from its direct
stimulatory effects on lymphoid (21, 22) and myeloid (23,
24) cells, l11r2 also regulates the production of other cytokines
likeIFN-y (25-28) . The nude mouse model provided an op-
portunity to study the function ofWencoded l1r2 in vivo
by analysis of theimmune mechanisms induced by IL2 that
allowed recovery from VV infection.
The highly "attenuated" phenotype ofVVHAlL2 in mice
was apparently due to antiviral mechanisms induced by virus-
encoded 1172, because experiments in vivo using mAbs to
IL2 to IFN-y clearly established that in these circumstances
VVHAIL2 could replicate to high titers in mouse tissues,
sometimes as high as the controlVVHATK. Therefore, the
reduced virulence ofVV-HA-1L2 did not result simply from
the insertion ofa second foreign gene into the VV genome .
Furthermore, the consequences of local IIr2 production in
foci of VVHAIL2 infection and subsequent activation of
antiviral mechanisms could not be mimicked by the adminis-
tration of exogenous rILr2 or rIFN-y at 8-h intervals over
the first 5 d of infection withVVHATK . All of these mice
Table 7.
No . of
mice
The Effect ofExogenous rIL-2 or rIFN-y
Virus'
Administration
Treatment
on Survival of Nude Mice Infected
Percent
survival
with VV-HA-TK
MTD
(death on days p.i.)
3 nil rIL-2 100 -
3 nil rIFN--y 100 -
5 VV-HA-IL2 - 100 -
5 VV-HA-TK - 0 12.2 (9, 11, 12, 14, 15)
5 VV-HA-TK rIL-2 0 23.4 (19, 21, 24, 25, 28)#
5 VV-HA-TK rIFN-y 0 25.8 (18, 23, 27, 28, 33)tultimately died, although death was delayed beyond the time
of death of untreated VVHATK-infected controls .
The results presented here demonstrate that in the com-
plete absence of classical CD8+ Tc cells, as-GM1+ (NK) and
as-GM1- cells (non-NK) can contribute to recovery from in-
fection with recombinantVV encoding murine Ilr2 . Deple-
tion of as-GMt+ cells in vivo exacerbated infection, though
not as much as anti-IFN-y mAb, thus indicating that NK
cells activated by virus-encoded 11,2 contributed to antiviral
activity and also suggesting the involvement ofnon-NK cells.
In the absence of IL2 producing functional T cells, virus-
encoded IL2 would be necessary for nude mouse lymphoid
cell activation and IFN-y secretion. Although IFN-y isknown
to be produced byNK cells after stimulation with IL2 (27,
28), our data suggest that in nude mice, as-GM, - cells may
also produce this cytokine . This could explain why NK
cell-depleted nude mice survived infection with VVHA-IL2
despite enhanced viral replication. The identity of these as-
GM, - cells is not known, but there is a possibility that they
are precursors ofNK or T cells. Furthermore, young adult,
athymic, nude mice have been shown to possess T cells that
express the TCR-y/S (29, 30) and that could produce cytokines
with antiviral activity, but further investigations are neces-
sary to confirm the role of this class of cells. Additionally,
since IL2 induces the differentiation of as-GM, - progenitors
to as-GM,+ cells (15), it is possible that in nude mice
depleted of as-GM,+ cells and infected with VVHA-IL2,
a regeneration of as-GMj+ cells from precursors may explain
why such mice survive.
NK cell responses were not inhibited by the mAb to IFN-y .
SplenicNK cell cytolytic activity, measured in vitro, was en-
hanced further in mAb-treated VVHAIL2-infected mice.
This could have been due to enhanced viral replication and
hence higher IL2 production, resulting in further NK cell
activation .
The finding that a proportion ofWHAIL2-infected mice
that had been treated with themAb againstIFN-y died from
IL2 toxicity is also consistent with increased IL2 produc-
tion resulting from increased titers ofVVHAIL2 . The high
levels of IL2 may have either directly, or through a cascade,
induced the secretion of other cytokines that are thought to
mediate, in part, the toxic effects of 1172 (31-33) . However,
we could not demonstrate the presence of one such cytokine,
TNF-a, in mice that showed signs of IL2 toxicity and in
which 11,2 was detectable in sera and ascitic fluid .
IFN-y may have contributed in a number ofpossible ways
to the limitation of viral replication and mediation ofrecovery
of nude mice . First, the induction of an antiviral state in unin-
fected cells surrounding infected foci could be one direct effect
ofIFN-y in preventing spread of infection. Second, IFN-'r
could have mediated antiviral activity in vivo through acti-
vation of mononuclear phagocytes . Both monocytes and mac-
rophages have a well-defined antiviral role in vivo (2, 34) and
anti-IFN-y mAb can abrogate the antiviral and antitumour
activities ofmacrophages (35) . Third, IFN-y upregulates the
expression of a2-microglobulin, which may be a ligand for
NK cell recognition and lysis of target cells (36) . Therefore,
treatment with themAb to IFN-y may have interfered with
target cell recognition and elimination ofvirally infected cells
by NK cells . Finally, IFN-y could have mediated antiviral
function in vivo in synergy with other host-derived antiviral
factors like TNF-oi/0 (37) and IFN-oi/J3 (38). However, our
preliminary results from experiments using antibodies to
TNF-ot and IFN-/3 suggests that both these cytokines may
not be crucial for the recovery of nude mice from infection
withVVHAIL2, assuming that the available antibodies were
efficient in blocking the activity of these factors in vivo .
The currently held view with regard to the role of Tc cells
in the host defense to viral infection is based on the capacity
of these effectors to recognize viral peptide in association with
theMHC class I molecule (39) on the surface of infected cells
followed by cytolysis (2, 40, 41) and local release of IFN-y
(2, 42, 43) . The IFN-y, released in an antigen-specific and
H-2-restricted fashion, could inhibit further spread of virus
either through antiviral effects on surrounding cells, or by
upregulation of class I MHC antigen expression, thus in-
creasing the efficiency of the cytotoxic function of Tc cells
(44, 45) . However, the mechanisms of recovery described in
this report involve "nonspecific" components oftheimmune
system that can clearly be activated to mediate efficiency an-
tiviral functions to compensate for the absence ofT cell-medi-
ated immune mechanisms in nude mice. These results fur-
ther support recent reports (46-48) that IFN-y is an essential
component of antiviral immune mechanisms and that IL2
is important for the induction and regulation ofIFN-'r produc-
tion in vivo, consistent with previous in vitro findings (25-28) .
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